SCHEMBL6601241

SCHEMBL6601241

COc1ccc(C(=O)Nc2ccc3c(c2Br)CNCC3)cc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.44
CYP2C19 P33261 3/20 0.44
KDM4E B2RXH2 3/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
PDE4D Q08499 1/20 0.43
ROCK2 O75116 3/20 0.42
PRKG1 Q13976 1/20 0.42
MEN1 O00255 2/20 0.39
HTT P42858 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
MELK Q14680 1/20 0.39
HDAC1 Q13547 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6605922 0.90 PDE4D (0.43) MAPTCYP2C19KDM4ECYP1A2CYP3A4
SCHEMBL6602306 0.90 MAPT (0.45) MAPTCYP2C19KDM4ECYP1A2CYP3A4
SCHEMBL8135404 0.89 ESR1 (0.42) MAPTCYP2C19KDM4ECYP1A2CYP3A4
SCHEMBL6602560 0.88 PDE4D (0.43) MAPTCYP2C19KDM4ECYP1A2CYP3A4
SCHEMBL7655287 0.84 MAPT (0.41) MAPTCYP2C19KDM4ECYP1A2CYP3A4
SCHEMBL6602300 0.83 PDE4D (0.42) MAPTCYP2C19KDM4ECYP1A2CYP3A4
SCHEMBL6601445 0.83 PDE4D (0.42) MAPTCYP2C19KDM4ECYP1A2CYP3A4
SCHEMBL7659817 0.83 PDE4D (0.42) MAPTCYP2C19KDM4ECYP1A2CYP3A4
SCHEMBL6602301 0.82 HDAC8 (0.48) MAPTCYP2C19KDM4ECYP1A2CYP3A4
SCHEMBL5874146 0.82 ROCK2 (0.45) MAPTCYP2C19KDM4ECYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP claimed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US claimed
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP disclosed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US disclosed
EP-1042296-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-10-11 EP disclosed
WO-1999031068-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-06-24 WO disclosed